Search Within

Department of Medicine

Formats
  1. Journal Article (19618)
  2. Meeting Abstract (16046)
  3. Review (1158)
  4. Book Section (934)
  5. Editorial (611)
  6. Research Letter (316)
  7. Conference Paper (301)
  8. Guidelines (298)
  9. Correspondence (236)
  10. Miscellaneous (90)
  11. Book Whole (61)
Groups
  1. Solid Tumor Oncology Division (22348)
  2. Hematologic Malignancies, Division of (13287)
  3. Center for Hematologic Malignancies (11069)
  4. GSK Faculty (10653)
  5. Survivorship Research (9346)
  6. Division of Subspecialty Medicine (7554)

More Groups

People
  1. Robert Motzer (1249)
  2. Howard Scher (1133)
  3. Sergio Giralt (1069)
  4. Miguel-Angel Perales (943)
  5. Clifford Hudis (906)
  6. Jedd Wolchok (905)

More People

Years
  1. 2025 (1118)
  2. 2024 (2291)
  3. 2023 (2452)
  4. 2022 (2621)
  5. 2021 (2534)
  6. 2020 (2563)

More Years

Publications
  1. Journal of Clinical Oncology (6125)
  2. Blood (3722)
  3. Annals of Oncology (1398)
  4. Cancer Research (1238)
  5. Clinical Cancer Research (902)
  6. Biology of Blood and Marrow Transplantation (679)

More Publications

Publishers
  1. American Society of Clinical Oncology (6458)
  2. Elsevier Inc. (4216)
  3. American Society of Hematology (4003)
  4. American Association for Cancer Research (2896)
  5. Oxford University Press (2291)
  6. Nature Publishing Group (2121)

More Publishers

Results (39669)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Does endoscopy accurately predict response to chemoradiation in patients undergoing esophagectomy?
    Meeting Abstract

    Sarkaria, I. S.; Rizk, N.; Bains, M.; Flores, R.; Park, B.; Ilson, D. H.; Minsky, B. D.; Rusch, V. W.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Simplification of bevacizumab (bev) administration: Do we need 90, 60, or even 30 minute infusion times?
    Meeting Abstract

    Saltz, L. B.; Chung, K. Y.; Timoney, J.; Park, V.; Hollywood, E.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Change in circulating endothelial cells (CEC) predicts progression free survival (PFS) in patients (pts) with hormone receptor positive metastatic breast cancer (MBC) receiving letrozole (L) and bevacizumab (B)
    Meeting Abstract

    Rugo, H. S.; Dickler, M. N.; Traina, T. A.; Scott, J. H.; Moore, D. H.; Bruckner, J.; Hudis, C.; Park, J. W.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Psychostimulants for fatigue in prostate cancer
    Meeting Abstract

    Roth, A. J.; Nelson, C. J.; Rosenfeld, B.; O'Shea, N.; Slovin, S.; Scher, H. I.; Breitbart, W.
    Psycho-Oncology (2006)

    Fulltext@MSK | Save
  • Randomized controlled trial testing methylphenidate as treatment for fatigue in men with prostate cancer
    Meeting Abstract

    Roth, A. J.; Nelson, C. J.; Rosenfeld, B.; O'Shea, N.; Slovin, S.
    Psycho-Oncology (2006)

    Fulltext@MSK | Save
  • CALGB 90207: Phase II trial of bortezomib in patients with previously treated advanced urothelial tract transitional cell carcinoma (TCC)
    Meeting Abstract

    Rosenberg, J. E.; Halabi, S.; Sanford, B. L.; Himelstein, A. L.; Atkins, J. N.; Hohl, R.; Seagren, S. L.; Bajorin, D. F.; Small, E. J.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • A phase I study of sunitinib malate (SU11248) in combination with gefitinib in patients with metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    Ronnen, E. A.; Kondagunta, G. V.; Lau, C.; Fischer, P.; Ginsberg, M. S.; Baum, M.; Kim, S. T.; Chen, I.; Baum, C. M.; Motzer, R. J.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Concordance with national comprehensive cancer network (NCCN) clinical practice guidelines (CPGs): A quality of care tool for newly diagnosed patients (pts) with mantle cell lymphoma (MCL)
    Meeting Abstract

    Rodriguez, M. A.; ter Veer, A.; Nademanee, A.; Niland, J.; Lepisto, E.; Kho, M.; LaCasce, A.; Weeks, J. C.; Czuczman, M.; Millenson, M.; more...
    Blood (2006)

    Fulltext@MSK | Save
  • Phase I/II study of ABI-007 as first line chemotherapy in advanced non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Rizvi, N. A.; Azzoli, C.; Miller, V.; Ng, K.; Fiore, J.; Chia, G.; Brower, M.; Heelan, R.; Hawkins, M.; Kris, M.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Impact of pre-operative chemoradiotherapy on post-esophagectomy morbidity and mortality
    Meeting Abstract

    Rizk, N. P.; Bains, M.; Flores, R.; Park, B.; Minsky, B.; Ilson, D.; Rusch, V.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save